1. Шахгильдян В.И. Цитомегаловирусная инфекция в кн. "Лекции по инфекционным болезням: в 2 т./Н.Д. Ющук, Ю.Я. Венгеров. 4-е изд., перераб. и доп. М.: ГЭОТАР-Медиа. 2016: Т. 2, 592 с.

2. Шахгильдян В.И. Цитомегаловирусная инфекция в "Вирусные болезни: учебное пособие/под ред. Н.Д. Ющука. М.: ГЭОТАР-Медиа, 2016: 540 с.

3. Львов Д.К. Руководство по вирусологии: Вирусные инфекции человека и животных. М.: Издательство "МИА", 2013: 1200 с.

4. Исаков В.А., Архипова Е.И., Исаков Д.В. Герпесвирусные инфекции человека. Руководство для врачей. СПб.: Спецлит, 2006: 302 с.

5. Инфекционные болезни: национальное руководство/под ред. Н.Д. Ющука, Ю.Я. Венгерова. - 3-е изд., перераб. и доп. - М.: ГЭОТАР-Медиа, 2021. - 1104 с.

6. Кистенева Л.Б. Цитомегаловирусная инфекция как проблема перинатальной патологии: этиология, патогенез, диагностика. Российский вестник перинатологии и педиатрии 2003; 4: С. 55 - 60.

7. Kosugi I. Cytomegalovirus (CMV). Virus 2010; 60(2): Р. 209 - 220.

8. Гусева Л.Н., Рогова Л.А., Егорова Н.Ю. и др. Цитомегаловирусная инфекция (ЦМВИ): классификация и варианты течения. Детские инфекции. 2003; 1: С. 57 - 61.

9. Скворцов В.В., Мязин Р.Г., Емельянов Д.Н. Цитомегаловирусная инфекция в клинике внутренних болезней. Лечащий врач 2004; 9: С. 8 - 11.

10. Sylwester A.W., Mitchell B.L., Edgar J.B. et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med. 2005; 202: Р. 673.

11. Gillespie G.M., Wills M.R., Appay V. et al. Functional heterogeneity and high frequencies of cytomegalovirus-specific CD 8(+) T lymphocytes in healthy seropositive donors. J Virol. 2000; 74: Р. 8140.

12. Корсакова И.И., Пашанина Т.П., Елизарова В.В. Основные параметры иммунного статуса у лиц с цитомегаловирусной инфекцией. Эпидемиология и инфекционные болезни. 2004; 3: С. 32 - 34.

13. Gandhi M.K., Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis. 2004; 4: Р. 725.

14. Gervasi M.T., Romero R., Bracalente G. et al. Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy. Matern Fetal Neonatal Med. 2012; 25(10): Р. 2002 - 2013.

15. Van den Berg A.P., van der Bij W., van Son W.J. Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation - report of 130 consequtive patients. Transplantation 1989; 48: Р. 991 - 996.

16. Ликарь Ю.Н., Пашанов Е.Д., Масчан А.А. Цитомегаловирусная инфекция после трансплантации гемопоэтических стволовых клеток (обзор литературы). Вопросы гематологии, онкологии и иммунопатологии в педиатрии. 2005; 4(2): С. 49 - 55.

17. Halfon Ph., Berger P., Khiri H. et al. Algorithm based on CMV kinetics DNA viral load for preemptive therapy initiation after hematopoietic cell transplantation. J. Med. Virol. 2011; 83(3): Р. 490 - 495.

18. Zhang X., Fan J., Yang M.F. et al. Monitoring of human cytomegalovirus infection in bone marrow and liver transplant recipients by antigenaemia assay and enzyme-linked immunosorbent assay. J. Int. Med. Res. 2009; 37(1): Р. 31 - 36.

19. Козлова А.В., Сюткин В.Е., Чжао А.В. Цитомегаловирусная инфекция и трансплантация печени. Инфекционные болезни. 2010; 3: С. 46 - 52.

20. Долгих Т.И., Черешнев В.А., Назарова О.Г. Распространенность и диагностика оппортунистических инфекций, вызванных цитомегаловирусом и парвовирусом B19 у больных с вторичными иммунодефицитами. Эпидемиология и инфекционные болезни. 2004; 4: С. 24 - 27.

21. Степанова Е.В. Герпесвирусные заболевания и ВИЧ-инфекция. Часть II. ВИЧ-инфекция и иммуносупрессии. 2010; 2 (1): С. 23 - 36.

22. Jabs D.A., Van Natta M.L., Kempen J.H. et al. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am. J. Ophthalmol.2000; 133: Р 48 - 61.

23. Teoh S.C., Wang P.X., Wong E.P. The epidemiology and incidence of cytomegalovirus retinitis in the HIV population in Singapore over 6 years. Invest. Ophthalmol. Vis. Sci. 2012; 53 (12): P. 7546 - 7552.

24. Amedia S.C., Penalva de Oliveira A.C., Vilas-Boas L. et al. Neurologic cytomegalovirus complications in patients with AIDS: Retrospective review of 13 cases and review of the literature. Rev. Inst. Med. Trop. S. Paulo. 2010; 52(6): Р. 303 - 310.

25. Squizzato A., Ageno W., Cattaneo A. et al. A case report and literature review of portal vein thrombosis associated with cytomegalovirus infection in immunocompetent patients. Clin Infect Dis. 2007; 44: e13.

26. Spahr L., Cerny A., Morard I. et al. Acute partial Budd-Chiari syndrome and portal vein thrombosis in cytomegalovirus primary infection: a case report. BMC Gastroenterol. 2006; 6: Р. 10.

27. Clarke J., Craig R.M., Saffro R. et al. Cytomegalovirus granulomatous hepatitis. Am J Med. 1979; 66: Р. 264.

28. Bonkowsky H.L., Lee R.V., Klatskin G.. Acute granulomatous hepatitis. Occurrence in cytomegalovirus mononucleosis. JAMA. 1975; 233: Р. 1284.

29. Bobak D.A. Gastrointestinal Infection Caused by Cytomegalovirus. Current Infectious Disease Reports. 2003; 5: P. 101 - 107.

30. Kaniel A., Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am. Journal Gastroenterology. 2006; 101: P. 2857 - 2865.

31. Барышников Е.Н., Дроздов В.Н., Шулятьев И.С., Парфенов А.И. Цитомегаловирусная инфекция у больных язвенным колитом. Экспериментальная и клиническая гастроэнтерология. 2010; 10: С. 25 - 28.

32. Cunha B.A. Cytomegalovirus pneumonia: community-acquired pneumonia in immunocompetent hosts. Infect. Dis. Clin. North Am. 2010; 24(1): Р. 147 - 158.

33. Шахгильдян В.И. Цитомегаловирусная инфекция. В кн. "Пневмония". Под ред. Чучалина А.Г., Синопальникова А.И., Страчунского Л.С. М.: ООО "Медицинское информационное агентство", 2006: 444 с.

34. Chee S.P., Jap A. Cytomegalovirus anterior uveitis: Outcome of treatment. Br. J. Ophthalmol. 2010; 94(12): Р. 1648 - 1652.

35. Orlikowski D., Porcher R., Sivadon-Tardy V. et al. Guillain-Barr syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis. 2011; 52: Р. 837.

36. Steininger C., Popow-Kraupp T., Seiser A. et al. Presence of cytomegalovirus in cerebrospinal fluid of patients with Guillain-Barre syndrome. J Infect Dis. 2004; 189: Р. 984.

37. Lurain N.S., Hanson B.A., Martinson J. et al. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J Infect Dis. 2013; 208: Р. 564.

38. , Vuorinen T., Saukko P. et al. Cytomegalovirus infection of the heart is common in patients with fatal myocarditis. Clin Infect Dis. 2005; 40: Р. 683.

39. Blum A., Giladi M., Weinberg M. et al. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol. 1998; 81: Р. 866.

40. Colomba C., Lalicata F., Siracusa L. et al. Cytomegalovirus infection in immunocompetent patients. Clinical and immunological considerations. Infez. Med. 2012; 20 (1): P. 12 - 15.

41. Eddleston M., Peacock S., Juniper M. et al. Severe cytomegalovirus infection in immunocompetent patients. Clin Infect Dis. 1997; 24: Р. 52.

42. Heininger A, Jahn G., Engel C. et al. Human cytomegalovirus infections in nonimmunosuppressed critically ill patients. Crit Care Med. 2001; 29: Р. 541.

43. De Vlieger G., Meersseman W., Lagrou K. et al. Cytomegalovirus serostatus and outcome in nonimmunocompromised critically ill patients. Crit Care Med. 2012; 40: Р. 36.

44. Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis. 1990; 12 Suppl 7: S701.

45. Выдумкина С.П., Зазимко Л.А., Кузенкова А.В. Частота острой цитомегаловирусной инфекции среди лиц разных возрастных групп. Вопр. вирусол. 1999; 1: С. 19 - 20.

46. Down J.B. Family poverty is associated with cytomegalovirus antibody titeris in U.S. children. Health Psychol. 2012; 31(1): Р. 5 - 10.

47. Staras S.A., Dollard S.C., Radford K.W. et al. Seroprevalence of cytomegalovirus infection in the United States, 1988 - 1994. Clin Infect Dis 2006; 43: Р. 1143.

48. Bate S.L., Dollard S.C., Cannon M.J. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988 - 2004. Clin Infect Dis 2010; 50: Р. 1439.

49. Luvira V., Chamnanchanunt S., Bussaratid V. et al. Seroprevalence of latent cytomegalovirus infection among elderly Thais. Southeast Asian J. Trop. Med. Publ. Hlth. 2012; 43(6): Р. 1419 - 1425.

50. Lopo S. Seroprevalence to cytomegalovirus in the Portuguese population, 2002 - 2003. Euro Surveill. 2011; 23(16): Р. 25 - 28.

51. De Fran a T.R., de Albuquerque Tavares Carvalho A., Gomes V.B. Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1.Clin. Oral Investig. 2012; 16 (2): P. 659 - 664.

52. Handsfield H.H., Chandler S.H., Caine V.A. et al. Cytomegalovirus infection in sex partners: evidence for sexual transmission. J Infect Dis. 1985; 151: Р. 344.

53. Jordan M.C., Rousseau W.E., Noble G.R. et al. Association of cervical cytomegaloviruses with venereal disease. N Engl J Med. 1973; 288: Р. 932.

54. Викулов Г.Х. Герпесвирусные инфекции человека в новом тысячелетии: классификация, эпидемиология и медико-социальное значение. Эпидемиология и инфекционные болезни. Актуальные вопросы. 2014; 3: 35 - 40.

55. Tolpin M.D., Stewart J.A., Warren D. et al. Transfusion transmission of cytomegalovirus confirmed by restriction endonuclease analysis. J Pediatr. 1985; 107: Р. 953.

56. Prince A.M., Szmuness W., Millian S.J. et al. A serologic study of cytomegalovirus infections associated with blood transfusions. N Engl J Med. 1971; 284: Р. 1125.

57. Colugnati F.A., Staras S.A., Dollard S.C., Cannon M.J. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 2007; 7: Р. 71.

58. Kenneson A., Cannon M.J. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev. Med. Virol. 2007; 17 (4): Р. 253 - 276.

59. Stadler L.P., Bernstein D.I., Callahan S.T. et al. Seroprevalence of cytomegalovirus (CMV) and risk factors for infection in adolescent males. Clin Infect Dis 2010; 51: e76.

60. Adler S.P. Molecular epidemiology of cytomegalovirus: viral transmission among children attending a day care center, their parents, and caretakers. J Pediatr. 1988; 112: Р. 366.

61. Blackman J.A., Murph J.R., Bale J.F. Jr. Risk of cytomegalovirus infection among educators and health care personnel serving disabled children. Pediatr Infect Dis J. 1987; 6: P. 725.

62. Sissons J.G.P., Carmishael A. J. Clinical aspects and management of cytomegalovirus infection. J. Infection. 2002; 44: P. 78 - 83.

63. Шульженко А.Е. Герпетические инфекции человека: перспективы диагностики и противовирусной терапии. Цитокины и воспаление. 2005; 3: С. 76 - 81.

64. Ross S.A., Novak Z., Pati S. et al. Diagnosis of Cytomegalovirus Infections. Infect Disord Drug Targets. 2011; 11(5): Р. 466 - 474.

65. Кистенева Л.Б., Мартынов К.А., Хижнякова Т.М. и др. Цитомегаловирусная инфекция у беременных. Диагностика, трактовка результатов обследования. Вопросы вирусологии. 2003; 48 (6): С. 4 - 8.

66. Кузьмин В.Н. Диагностика, лечение и профилактика цитомегаловирусной инфекции у беременных. Лечащий врач. 2002; 11: С. 22 - 25.

67. Griffits P.D. Diagnosis of cytomegalovirus infection. The Journal of Antimicrobal Chemotheraphy. 1989; 23 (Suppl. E): Р. 11 - 16.

68. Каражас Н.В., Рыбалкина Т.Н., Евсеева Л.Ф. Лабораторная диагностика цитомегаловирусной инфекции. Журнал микробиологии, эпидемиологии и иммунологии. 2000; 8: С. 15 - 16.

69. Bonalumi S., Trapanese A., Santamaria A. et al. Cytomegalovirus infection in pregnancy: review of the literature. Journal of Prenatal Medicine 2011; 5(1): Р. 1 - 8.

70. Revello M.G., Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus and newborn infant. Clin. Microbiol. Rev. 2002; 15(4): P. 680 - 715.

71. Szenborn L. Significance of diagnostics and treatment in preventing congenital infections with Toxoplasma gondii (Tg), cytomegalovirus (CMV) and parvowirus B19 (PVB19). Przegl. Lek. 2010; 67 (1): Р. 54 - 57.

72. Эбрамидзе Л.Н., Ведунова С.Л., Мальцева Н.Н. Иммуноферментная тест-система для выявления низкоавидных иммуноглобулинов G-антител к цитомегаловирусу человека ("Цитомегаловирус-диагностикум") - перспективный подход к диагностике первичной герпетической инфекции. Вопросы вирусологии. 2004; 2: С. 46 - 49.

73. Шахгильдян В.И., Шипулина О.Ю., Каражас Н.В. и др. Лабораторная диагностика цитомегаловирусной инфекции у ВИЧ-инфицированных пациентов. Эпидемиология и инфекционные болезни. 2001; 1: С. 36 - 40.

74. Шахгильдян В.И., Шипулина О.Ю., Сильц В.В., и др. Значение лабораторных маркеров активной репликации цитомегаловируса у ВИЧ-инфицированных беременных женщин при оценке риска врожденной и внутриутробной цитомегаловирусной инфекции. Эпидемиология и инфекционные болезни 2004; 4: С. 30 - 34.

75. Leung J., Cannon M.J., Grosse S.D., Bialek S.R. Laboratory testing for cytomegalovirus among pregnant women in the United States: a retrospective study using administrative claims data BMC Infectious Diseases. 2012; 12: Р. 334.

76. Leung J., Cannon M.J., Grosse S.D., Bialek S.R. Laboratory testing and diagnostic coding for cytomegalovirus among privately insured infants in the United States: a retrospective study using administrative claims data. BMC Pediatrics 2013; 13: Р. 90.

77. Eisen H.N., Siskin G.M. Variation in affinities of antibodyes during the immune respons. Biochemisry. 1964; 3: P. 966 - 1008.

78. Jiang H., Wen L., Ling X. Diagnostic value of human cytomegalovirus late m RMA dertection inactive intrauterine infection. Clin. Med. J. 2002; 115 (1): Р. 1507 - 1509.

79. Lassaroto T., Gall C. Envaluation of the Abbott Ax SYM cytomegalovirus IgG assay in conjunction with other CMV JgM tests and CMV JgG-avidity assay. Clin. Diagn. Lab. Immunol. 2001; 1: P. 196 - 199.

80. Alves Bonon S.H., Rossi C.L., De Souza C.A. Comparison of serology, antigenemia assay for the polymerase chain reaction for monitoring active cytomegalovirus infections in hematopoietic stem cell transplantation patients. Rev. Inst. Med. Trop. S. Paulo. 2006; 48(5): Р. 275 - 278.

81. Aspin M.M., Gallez-Hawkins G.M., Guigni T.D., et al. Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients. J Clin Microbiol 1994; 32: Р. 2266 - 2269.

82. Fregmuth F., Gennetay E., Petitjean J. et al. Comparison of nested PCR for detection of DNA in plasma with PP65 leucocytic antigenemia procedure for diagnosis human cytomegalovirus infection. J Clin Microbiol 1994; 32: Р. 1614 - 1618.

83. Hansen K.K., Ricksten A., m Hoffmann B. et al. Detection of cytomegalovirus DNA in serum correlstes with clinical cytomegalovirus retinitis in AIDS. J. Infect. Dis., 1994; 170: Р. 1271 - 1274.

84. Drew W.L. Cytomegalovirus resistance testing: pitfalls and problems for the clinician. Clin. Infect. Dis. 2010; 50 (5): Р. 733 - 736.

85. Макарова Н.Е. Получение моноклональных антител к сверхранним белкам цитомегаловируса человека и их применение для выявления инфицированных клеток. Вопр. вирусологии. 1996; 41(1): С. 28 - 32.

86. Paradowska E., Prezikevich M., Nowakowska D. Detection of cytomegalovirus in human placental cells by polymerase chain reaction.APMIS. 2006; 114 (11): Р. 764 - 771.

87. Меджидова А.А. Сравнение различных методов лабораторной диагностики при выявлении цитомегаловируса в аутопсийном материале умерших новорожденных и детей, умерших на первом году жизни. ЖМЭИ. 2000; 3 (2): С. 63 - 69.

88. Reed Е.С., Bowden R.A., Dandliker P.S. et al. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 1988; 15: Р. 783 - 788.

89. Laing R.B., Dykhuizen R.S., Smith C.C. et al. Parenteral ganciclovir treatment of acute CMV infection in the immunocompetent host. Infection 1997; 25: Р. 44.

90. Serna-Higuera C., , Milicua J.M. et al. Acute cholestatic hepatitis by cytomegalovirus in an immunocompetent patient resolved with ganciclovir. J Clin Gastroenterol. 1999; 29: Р. 276.

91. Buonuomo P.S., Maurizi P., Valentini P. et al. Successful treatment with oral valganciclovir in immunocompetent infant with gastrointestinal manifestations of cytomegalovirus infection. J Perinatol. 2006; 26: Р. 648.

92. , , et al. Cytomegalovirus myopericarditis and hepatitis in an immunocompetent adult: successful treatment with oral valganciclovir. Intern Med. 2008; 47: Р. 1963.

93. Шахгильдян В.И., Галина М.В., Шамшурина М.К., Сильц В.В. Первый случай применения валганцикловира для лечения цитомегаловирусной инфекции у ВИЧ-инфицированной беременной женщины. Эпидемиология и инфекционные болезни 2008; 3: С. 60 - 65.

94. Jonjic S., Pavic J., Polic В. et al. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 1994; 179(5): Р. 1713 - 1717.

95. Andereoni K.J., Nang X., Huang S.-M., Huang E.S. Human cytomegalovirus hyperimmune globuli not only neutralizes HCMV infectivity but also inhibits HCMV-induced intracellular NF-KB. J Med Virol. 2002; 67(1): Р. 33 - 40.

96. Чешик С.Г., Кистенева Л.Б., Стаханова В.М. и др. Диагностика и лечение цитомегаловирусной инфекции у беременных женщин. Инфекционные болезни. 2005; 3 (2): С. 31 - 36.

97. Баринский И.Ф., Алимбарова Л.М. Препараты для лечения герпетической инфекции. Российские аптеки. 2005; 71 (1): С. 30 - 33.

98. Исаков В.А., Исаков Д.В. Иммуномодуляторы в терапии и профилактике герпесвирусных инфекций. Клиническая медицина. 2015; 93(4): С. 16 - 24.

99. Змушко Е.И., Шувалова Е.Е., Кацалуха В.В., Старенченко В.В. Сравнительная оценка эффективности индукторов интерферона при экспериментальной генерализованной герпетической инфекции. Инфекционные болезни. 2014; 12(2): С. 59 - 63.

100. Зуйкова И.Н., Шульженко А.Е., Щубелко Р.В. Коррекция цитокиновых нарушений у пациентов с хронической рецидивирующей герпесвирусной инфекцией. Фарматека. 2014; 10 (283): С. 48 - 54.

101. Bonaros N., Mayer B., Schachner N. et al. CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a metaanalysis. Clin. Transplant. 2008; 22(1): Р. 89 - 87.

102. Sia I., Patel R. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev 2000; (1): Р. 83 - 121.

103. Walker S.P., Palma-Dias R., Wood E. et al. Cytomegalovirus in pregnancy: to screen or not to screen. BMC Pregnancy and Childbirth 2013, 13: Р. 96.

104. Carlson A., Norwitz E.R., Stiller R.J. Cytomegalovirus Infection in Pregnancy: Should All Women Be Screened? Rev Obstet Gynecol. 2010; 3(4): Р. 172 - 179.

105. Ornoy A. Fetal Effects of Primary and Non-primary Cytomegalovirus Infection in Pregnancy: Are we Close to Prevention? IMAJ 2007, May, 9: Р. 398 - 401.

106. Johnson J., Anderson B., Pass RF. Prevention of Maternal and Congenital Cytomegalovirus Infection. Clin Obstet Gynecol. 2012 June; 55(2): Р. 521 - 530.

107. Прокопенко Е.И., Щербакова Е.О., Ватазин А.В. и др. Результаты профилактики цитомегаловирусной инфекции валганцикловиром у пациентов с трансплантированной почкой. Клиническая нефрология. 2013; 5: С. 37 - 41.

108. Hirsch H.H., Lautenschlager I., Pinsky B.A. et al. An international multicenter perfomance analysis of cytomegalovirus load tests//Clin Infect Dis. 2013. Vol. 56. P. 367.

109. Humar A., Limaye A.P., Blumberg E.A. et al. Extended valganciclovir prophylaxis in D+/R-kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study. Transplantation. 2010; 90: P. 1427.

110. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009; 9 (Suppl 3): S1 - S157.

111. Kotton C.N., Kumar D., Caliendo A.M. et al. Updated international consensus guidelines on the managament of cytomegalovirus in solid-organ transplantation//Transplantation. 2013; 96: P. 333 - 360.

112. Rostaing L., W clawiak H., Mengelle C., Kamar N. Viral infections after kidney transplantation. Minerva Urol Nefrol. - 2011; 63(1): P. 59 - 71.

113. Городин В.Н. Жукова Л.И. Ковалевская О.И. Шахвердян Ю.Г. Цитомегаловирусная инфекция (учебно-методич. пособие). - Краснодар. - 2016. - 112 с.

114. Limaye A.P., Stapleton R.D., Peng L. et al. Effect of ganciclovir on IL-6 levels among cytomegalovirus-seropositive adults with critical illness: a randomized clinical trial. JAMA. 2017; 318: 731 - 740.

115. Tay M.R., Lim S.T., Tao M. et al. Cytomegalovirus infection and end-organ disease in Asian patients with lymphoma receiving chemotherapy. Leuk Lymphoma. 2014; 55: 182 - 187.

116. Green M.L., Leisenring W., Xie H. et al. Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study. Lancet Haematol. 2016; 3: e119 - e127.

117. Ljungman P., Boeckh M., Hirsch H.H. et al. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis. 2017; 64: 87 - 91.

118. Kotton CN, Kumar D, Caliendo AM, et al. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. Transplantation 2018; 102: 900.

119. Caliendo AM. The long road toward standardization of viral load testing for cytomegalovirus. Clin Infect Dis 2013; 56: 374.

120. Hayden RT, Sun Y, Tang L, et al. Progress in Quantitative Viral Load Testing: Variability and Impact of the WHO Quantitative International Standards. J Clin Microbiol 2017; 55: 423.

121. Lodding IP, Schultz HH, Jensen JU, et al. Cytomegalovirus Viral Load in Bronchoalveolar Lavage to Diagnose Lung Transplant Associated CMV Pneumonia. Transplantation 2018; 102: 326.

122. Westall GP, Cristiano Y, Levvey BJ, et al. A Randomized Study of Quantiferon CMV-directed Versus Fixed-duration Valganciclovir Prophylaxis to Reduce Late CMV After Lung Transplantation. Transplantation 2019; 103: 1005.

123. Fisher CE, Knudsen JL, Lease ED, et al. Risk Factors and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in Solid Organ Transplant Recipients. Clin Infect Dis 2017; 65: 57.

124. Khurana MP, Lodding IP, Mocroft A, et al. Risk Factors for Failure of Primary (Val) ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients. Open Forum Infect Dis 2019; 6: ofz215.

125. Braccio S., Irwin A., Riordan A. et al. Acute infectious hepatitis in hospitalised children: a British Paediatric Surveillance Unit study. Arch Dis Child. 2017; 102: 624 - 628.

126. Zheng QY, Huynh KT, van Zuylen WJ, Craig ME, Rawlinson WD. Cytomegalovirus infection in day care centres: A systematic review and meta-analysis of prevalence of infection in children. Rev Med Virol. 2019 Jan; 29(1): e2011. doi: 10.1002/rmv.2011.

127. Public Health England. Sexually transmitted infections (STIs): annual data tables. https://www.gov.uk/government/statistics/sexually-transmitted-infections-stis-annual-data-tables. Date accessed: October 9, 2018.

128. Bartlett A.W., Hall B.M., Palasanthiran P., McMullan B., Shand A.W., Rawlinson W.D. Recognition, treatment, and sequelae of congenital cytomegalovirus in Australia: an observational study. J Clin Virol. 2018; 108: 121 - 125.

129. Rawlinson W.D., Boppana S.B., Fowler K.B. et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017; 17: e177 - e188.

130. Muldoon K.M., Armstrong-Heimsoth A., Thomas J. Knowledge of congenital cytomegalovirus (cCMV) among physical and occupational therapists in the United States. PLoS One. 2017; 12e0185635.

131. Utah Department of Health. Cytomegalovirus (CMV) public health initiative. http://health.utah.gov/cshcn/programs/cmv.html (accessed Feb 10, 2017).

132. Akhter K., Wills T.S., Talavera F., King J.W. Cytomegalovirus (CMV)/MedScape. Infectious Diseases Society of America. https://emedicine.medscape.com/article/215702-overview/ Updated: May 05, 2018.

133. Bolyard E, Tablan O, Williams W, Pearson M, Shapiro C, Deitchmann S. Guideline for infection control in health care personnel. Centers for Disease Control and Prevention. Infection Control and. Hosp Epidemiol. 1998; 19: 408-63.

134. Stagno S, Whitley R. Herpesvirus infections of pregnancy. Part 1: Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med. 1985; 313: 1270-4.

135. Balegamire SJ, McClymont E, Croteau A, Dodin P, Gantt S, Besharati AA, Renaud C, M sse B, Boucoiran I. Prevalence, incidence, and risk factors associated with cytomegalovirus infection in healthcare and childcare worker: a systematic review and meta-analysis. Syst Rev. 2022 Jun 27; 11(1): 131. doi: 10.1186/s13643-022-02004-4.

136. Trombetta CM, Viviani S, Montomoli E, Marchi S. Seroprevalence of antibodies to cytomegalovirus in pregnant women in the Apulia region (Italy). J Prev Med Hyg. 2021 Jul 30; 62(2): E372 - E376. doi: 10.15167/2421-4248/jpmh2021.62.2.1800.

137. Leruez-Ville M(1), Foulon I(2), Pass R(3), Ville Y(4). Leruez-Ville M, Foulon I, Pass R, Ville Y. Cytomegalovirus infection during pregnancy: state of the science. Am J Obstet Gynecol. 2020 Sep; 223(3): 330 - 349. doi: 10.1016/j.ajog.2020.02.018.

138. Lazzarotto T, , Delforge ML, Foulon I, Luck S, Modrow S, Leruez-Ville M. Congenital Cytomegalovirus Infection: A Narrative Review of the Issues in Screening and Management From a Panel of European Experts. Front Pediatr. 2020 Jan 31; 8: 13. doi: 10.3389/fped.2020.00013.

139. Carmona AS, Kakkar F, Gantt S. Perinatal Cytomegalovirus Infection. Curr Treat Options Pediatr. 2022; 8(4): 395 - 411. doi: 10.1007/s40746-022-00261-y.

140. Tanimura K, Yamada H. Potential Biomarkers for Predicting Congenital Cytomegalovirus Infection. Int J Mol Sci. 2018 Nov 27; 19(12): 3760. doi: 10.3390/ijms19123760.

141. D'Antonio F, Marinceu D, Prasad S, Khalil A. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022 Dec 9. doi: 10.1002/uog.26136.

142. Sapuan S, Theodosiou AA, Strang BL, Heath PT, Jones CE. A systematic review and meta-analysis of the prevalence of human cytomegalovirus shedding in seropositive pregnant women. Rev Med Virol. 2022 Nov; 32(6): e2399. doi: 10.1002/rmv.2399.

143. Iijima S. Pitfalls in the Serological Evaluation of Maternal Cytomegalovirus Infection as a Potential Cause of Fetal and Neonatal Involvements: A Narrative Literature Review. J Clin Med. 2022 Aug 26; 11(17): 5006. doi: 10.3390/jcm11175006.

144. El-Qushayri AE, Ghozy S, Abbas AS, Dibas M, Dahy A, Mahmoud AR, Afifi AM, El-Khazragy N. Hyperimmunoglobulin therapy for the prevention and treatment of congenital cytomegalovirus: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2021 May; 19(5): 661 - 669. doi: 10.1080/14787210.2021.1846521.

145. Chatzakis C, Sotiriadis A, Dinas K, Ville Y. Neonatal and long-term outcomes of infants with congenital cytomegalovirus infection and negative amniocentesis: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2023 Feb; 61(2): 158 - 167. doi: 10.1002/uog.26128.

146. Yassine BB, Hulkower R, Dollard S, Cahill E, Lanzieri T. A Legal Mapping Assessment of Cytomegalovirus-Related Laws in the United States. J Public Health Manag Pract. 2022 Mar-Apr 01; 28(2): E624 - E629. doi: 10.1097/PHH.0000000000001401.

147. Konjenital Sitomegalovir s Enfeksiyonlar n n Tan ve Y netiminde G ncel Yakla mlar ve T rkiye'deki Durum [Current Approaches in the Diagnosis and Management of Congenital Cytomegalovirus Infections and the Situation in Turkey]. Mikrobiyol Bul. 2020 Jan; 54(1): 171 - 190. Turkish. doi: 10.5578/mb.68978.

148. Gatta LA, Rochat E, Weber JM, Valencia S, Erkanli A, Dotters-Katz SK, Permar S, Hughes BL. Clinical factors associated with cytomegalovirus shedding among seropositive pregnant women. Am J Obstet Gynecol MFM. 2022 Mar; 4(2): 100560. doi: 10.1016/j.ajogmf.2021.100560.

149. Barbosa NG, Yamamoto AY, Duarte G, Aragon DC, Fowler KB, Boppana S, Britt WJ, Mussi-Pinhata MM. Cytomegalovirus Shedding in Seropositive Pregnant Women From a High-Seroprevalence Population: The Brazilian Cytomegalovirus Hearing and Maternal Secondary Infection Study. Clin Infect Dis. 2018 Aug 16; 67(5): 743 - 750. doi: 10.1093/cid/ciy166.

150. Gatta LA, Rochat E, Weber JM, Valencia S, Erkanli A, Dotters-Katz SK, Permar S, Hughes BL. Clinical factors associated with cytomegalovirus shedding among seropositive pregnant women. Am J Obstet Gynecol MFM. 2022 Mar; 4(2): 100560. doi: 10.1016/j.ajogmf.2021.100560.

151. Gorun F, Motoi S, Malita D, Navolan DB, Nemescu D, Olariu TR, Craina M, Vilibic-Cavlek T, Ciohat I, Boda D, Dobrescu A. Cytomegalovirus seroprevalence in pregnant women in the western region of Romania: A large-scale study. Exp Ther Med. 2020 Sep; 20(3): 2439 - 2443. doi: 10.3892/etm.2020.8945. Epub 2020 Jun 25.

152. Zhou Q, Wang Q, Shen H, Zhang Y, Zhang S, Li X, Acharya G. Seroprevalence of Cytomegalovirus and Associated Factors Among Preconception Women: A Cross-Sectional Nationwide Study in China. Front Public Health. 2021 Aug 25; 9: 631411. doi: 10.3389/fpubh.2021.631411.

153. Fowler KB, Boppana SB. Congenital cytomegalovirus infection. Semin Perinatol. 2018 Apr; 42(3): 149 - 154. doi: 10.1053/j.semperi.2018.02.002. Epub 2018 Mar 2. PMID: 29503048.

154. , Belhadi D, , Mandelbrot L, Picone O, Vauloup-Fellous C. Current practices of management of maternal and congenital Cytomegalovirus infection during pregnancy after a maternal primary infection occurring in first trimester of pregnancy: Systematic review. PLoS One. 2021 Dec 3; 16(12): e0261011. doi: 10.1371/journal.pone.0261011.

155. Deka S, Kalita D, Paul M, Badoni G, Mathuria YP. Seroprevalence and Determinants of ToRCH Pathogens in Pregnant Women in the Sub-Himalayan Region. Cureus. 2022 Feb 5; 14(2): e21946. doi: 10.7759/cureus.21946. PMID: 35273887.

156. Huang Y, Li T, Yu H, Tang J, Song Q, Guo X, Wang H, Li C, Wang J, Liang C, Yao X, Qiu L, Zhuang C, Bi Z, Su Y, Wu T, Ge S, Zhang J. Maternal CMV seroprevalence rate in early gestation and congenital cytomegalovirus infection in a Chinese population. Emerg Microbes Infect. 2021 Dec; 10(1): 1824 - 1831. doi: 10.1080/22221751.2021.1969290.

157. Саматова Л.Д., Раимова Д.А., Сабурова Ю.Т. Клиническое значение, подходы к диагностике и лечению активной цитомегаловирусной инфекции//Academic research in educational sciences. - 2021. - Т. 2. - N. 5. - С. 738 - 746.

158. Шахгильдян В.И. Лекция 23. Цитомегаловирусная инфекция //Лекции по ВИЧ-инфекции. - С. 293.

159. Kamatani K, Kenzaka T, Sugimoto R, Kumabe A, Kitao A, Akita H. Multiple thrombosis associated with Cytomegalovirus enterocolitis in an immunocompetent patient: a case report. BMC Infect Dis. 2021 Jun 5; 21(1): 530. doi: 10.1186/s12879-021-06230-4. PMID: 34090366; PMCID: PMC8180152.

160. Padala SK, Kumar A, Padala S. Fulminant cytomegalovirus myocarditis in an immunocompetent host: resolution with oral valganciclovir. Tex Heart Inst J. 2014 Oct 1; 41(5): 523-9. doi: 10.14503/THIJ-13-3504. PMID: 25425988; PMCID: PMC4189357.

161. Wasey W, Badesha N, Rossi M, Carter C, Bibee S. Cytomegalovirus-Induced Pericarditis, Pulmonary Embolism, and Transaminitis in an Immunocompetent Patient. Cureus. 2021 Nov 5; 13(11): e19285. doi: 10.7759/cureus.19285. PMID: 34900468; PMCID: PMC8648299.

162. Elfors MA, Helmy MGE, Mahmoud HEA, Hussein MM, Naguib AM, Ahmed MBED, Elbaz HSI, Aly Aly MO. Risk factors affecting the incidence of CMV infection in recipients after living donor liver transplantation. BMC Gastroenterol. 2025 Jun 25; 25(1): 440. doi: 10.1186/s12876-025-03911-1. PMID: 40563087; PMCID: PMC12188661.

163. Кочкина С.С., Ситникова Е.П. Особенности цитомегаловирусной инфекции: обзор литературы//Доктор.ру. - 2016. - N. 6 (123). - С. 62 - 67.

164. Salgado OJ, Henr quez C, Rosales B, Mart n MG, Garc a R, Rodr guez-Iturbe B. Renal Doppler sonographic and histologic findings in post-transplant primary cytomegalovirus disease. J Clin Ultrasound. 2000 Oct; 28(8): 430-4. doi: 10.1002/1097-0096(200010)28:8<430::aid-jcu9>3.0.co;2-y. PMID: 10993972.